Baxter ROE 2010-2025 | BAX
Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Baxter ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.56B | $7.05B | -7.53% |
| 2024-12-31 | $-0.65B | $7.02B | -8.40% |
| 2024-09-30 | $0.11B | $7.94B | 1.34% |
| 2024-06-30 | $2.48B | $7.71B | 30.40% |
| 2024-03-31 | $2.65B | $8.24B | 34.74% |
| 2023-12-31 | $2.66B | $8.47B | 37.67% |
| 2023-09-30 | $2.59B | $8.17B | 40.45% |
| 2023-06-30 | $-2.85B | $5.63B | -49.52% |
| 2023-03-31 | $-2.46B | $5.94B | -37.39% |
| 2022-12-31 | $-2.43B | $5.90B | -32.99% |
| 2022-09-30 | $-2.38B | $5.58B | -29.04% |
| 2022-06-30 | $1.01B | $8.90B | 11.25% |
| 2022-03-31 | $1.06B | $9.12B | 11.88% |
| 2021-12-31 | $1.28B | $9.12B | 14.69% |
| 2021-09-30 | $1.21B | $8.82B | 14.05% |
| 2021-06-30 | $1.12B | $8.54B | 13.04% |
| 2021-03-31 | $1.07B | $8.49B | 12.57% |
| 2020-12-31 | $1.10B | $8.73B | 13.27% |
| 2020-09-30 | $0.91B | $8.60B | 11.25% |
| 2020-06-30 | $0.92B | $8.16B | 11.76% |
| 2020-03-31 | $0.99B | $7.73B | 12.75% |
| 2019-12-31 | $1.00B | $7.91B | 12.90% |
| 2019-09-30 | $1.32B | $7.62B | 17.04% |
| 2019-06-30 | $1.47B | $7.84B | 18.09% |
| 2019-03-31 | $1.50B | $7.67B | 17.89% |
| 2018-12-31 | $1.55B | $7.87B | 17.70% |
| 2018-09-30 | $1.06B | $9.11B | 11.76% |
| 2018-06-30 | $0.80B | $8.87B | 8.73% |
| 2018-03-31 | $0.72B | $9.09B | 7.81% |
| 2017-12-31 | $0.60B | $9.12B | 6.61% |
| 2017-09-30 | $1.03B | $9.46B | 11.59% |
| 2017-06-30 | $0.91B | $9.17B | 10.46% |
| 2017-03-31 | $1.86B | $8.68B | 21.76% |
| 2016-12-31 | $4.97B | $8.28B | 57.61% |
| 2016-09-30 | $4.93B | $8.66B | 56.21% |
| 2016-06-30 | $4.80B | $8.51B | 56.05% |
| 2016-03-31 | $3.92B | $9.02B | 46.43% |
| 2015-12-31 | $0.97B | $8.87B | 12.09% |
| 2015-09-30 | $1.72B | $7.85B | 21.92% |
| 2015-06-30 | $2.18B | $8.02B | 27.38% |
| 2015-03-31 | $2.37B | $7.29B | 29.13% |
| 2014-12-31 | $2.50B | $8.16B | 29.41% |
| 2014-09-30 | $1.87B | $8.43B | 21.81% |
| 2014-06-30 | $1.95B | $8.69B | 23.16% |
| 2014-03-31 | $2.02B | $8.69B | 25.01% |
| 2013-12-31 | $2.01B | $8.49B | 26.35% |
| 2013-09-30 | $2.18B | $7.75B | 30.03% |
| 2013-06-30 | $2.22B | $7.32B | 31.16% |
| 2013-03-31 | $2.29B | $7.00B | 32.97% |
| 2012-12-31 | $2.33B | $6.98B | 33.54% |
| 2012-09-30 | $2.30B | $7.19B | 33.27% |
| 2012-06-30 | $2.29B | $6.61B | 33.17% |
| 2012-03-31 | $2.24B | $6.96B | 31.77% |
| 2011-12-31 | $2.22B | $6.83B | 31.51% |
| 2011-09-30 | $2.18B | $7.19B | 30.98% |
| 2011-06-30 | $2.13B | $7.24B | 30.72% |
| 2011-03-31 | $2.05B | $6.97B | 30.80% |
| 2010-12-31 | $1.42B | $6.80B | 21.55% |
| 2010-09-30 | $1.57B | $6.76B | 23.27% |
| 2010-06-30 | $1.57B | $6.13B | 22.87% |
| 2010-03-31 | $1.63B | $6.66B | 23.09% |
| 2009-12-31 | $2.21B | $7.42B | 31.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.652B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.564B | 27.96 |
| Boston Scientific (BSX) | United States | $154.721B | 38.73 |
| Stryker (SYK) | United States | $149.011B | 31.16 |
| EssilorLuxottica (ESLOY) | France | $125.383B | 0.00 |
| Medtronic (MDT) | Ireland | $110.530B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.919B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.856B | 26.72 |
| ResMed (RMD) | United States | $37.567B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.277B | 16.27 |
| Agilent Technologies (A) | United States | $33.923B | 22.11 |
| Terumo (TRUMY) | Japan | $27.568B | 35.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $21.804B | 85.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.231B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.625B | 23.06 |
| Lantheus Holdings (LNTH) | United States | $5.586B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.010B | 17.91 |
| Perrigo (PRGO) | Ireland | $3.653B | 9.26 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.330B | 27.68 |
| ICU Medical (ICUI) | United States | $3.216B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.941B | 13.35 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.62 |
| AtriCure (ATRC) | United States | $1.628B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.271B | 12.90 |
| Acuren (TIC) | United States | $1.252B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| Neogen (NEOG) | United States | $1.040B | 13.31 |
| BioLife Solutions (BLFS) | United States | $1.020B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.018B | 13.02 |
| Kestra Medical Technologies (KMTS) | United States | $0.919B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.96 |
| CeriBell (CBLL) | United States | $0.697B | 0.00 |
| Owens & Minor (OMI) | United States | $0.644B | 5.34 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.489B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.50 |
| Aurora Cannabis (ACB) | Canada | $0.239B | 71.00 |
| Biote (BTMD) | United States | $0.234B | 6.58 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.79 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.079B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.079B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 60.57 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |